VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers

Summary

This is a 2-part, drug-drug interaction study to evaluate potential PK interactions after single doses in Part 1 and multiple doses in Part 2. In Part 1, subjects will receive single dose of 5 treatments in a cross-over design; in Part 2 subjects will receive treatment for 10 days.

Timeline

Start

2017-10-24

Primary completion

2017-12-20

Completion

2017-12-20

Drugs

Indications